Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

REPLIGEN CORPORATION

(RGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Repligen Corporation
Repligen Corporation is a life sciences company that develops and commercializes bioprocessing technologies and systems that rises flexibility in the process of manufacturing biological drugs. The Company's bioprocessing business consist of four franchises, Filtration; Chromatography; Process Analytics; and Proteins. The Filtration products are used in process development and process scale (clinical and commercial) production. The Chromatography franchise includes products used in downstream purification, development, and manufacturing of biological drugs. The Process Analytics products allow end-users to make in-line absorbance measurements allowing for the determination of protein concentration in filtration, chromatography formulation and fill-finish applications. The Proteins franchise is represented by its Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification of virtually all mAb-based drugs on the market.

Number of employees : 1 128 people.
Sales per Business
20192020Delta
Filtration119.5344.2%174.9047.8% +46.31%
Proteins65.1224.1%80.7322% +23.97%
Chromatography64.6423.9%73.5520.1% +13.79%
Process Analytics16.416.1%33.359.1% +103.27%
Other Product4.401.6%3.611% -17.91%
Royalty and Other0.150.1%0.120% -16.22%
USD in Million
Sales per region
20192020Delta
North America137.8351%175.8148% +27.56%
Europe99.9937%139.1838% +39.19%
APAC32.4312%51.2814% +58.12%
USD in Million
Managers
Name Title Age Since
Tony Hunt President, Chief Executive Officer & Director 57 2015
Jon Snodgres Chief Financial Officer 55 -
Ralf Kuriyel Senior Vice President-Research & Development 62 2016
Jim Bylund Chief Operating Officer 58 2022
Squire Servance Secretary, Chief Compliance Officer & Senior VP - -
Thomas F. Ryan Independent Director 79 2003
Karen Dawes Chairman 69 2012
Nicolas M. Barthelemy Independent Director 55 2014
Glenn P. Muir Independent Director 62 2015
Rohin Mhatre, Dr. Independent Director 56 2020
Members of the board
Name Title Age Since
Karen Dawes Chairman 69 2012
Thomas F. Ryan Independent Director 79 2003
Tony Hunt President, Chief Executive Officer & Director 57 2015
Nicolas M. Barthelemy Independent Director 55 2014
Glenn P. Muir Independent Director 62 2015
Rohin Mhatre, Dr. Independent Director 56 2020
Carrie Eglinton Manner Independent Director 47 2020
Shareholders
NameEquities%
The Vanguard Group, Inc. 4,789,457 8.66%
Roy T. Eddleman 3,500,000 6.33%
T. Rowe Price Associates, Inc. (Investment Management) 2,305,449 4.17%
BVF Partners LP 1,810,535 3.27%
Invesco Advisers, Inc. 1,800,506 3.26%
Fred Alger Management LLC 1,573,998 2.85%
BlackRock Fund Advisors 1,463,785 2.65%
SSgA Funds Management, Inc. 1,312,614 2.37%
WCM Investment Management LLC 1,310,612 2.37%
Select Equity Group LP 1,285,796 2.33%
Company contact information
Repligen Corp.
41 Seyon Street
Building 1
Suite 100
Waltham, MA 02453

Phone : +1.781.250.0111
Fax : +1.781.250.0115
Web : http://www.repligen.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Repligen Corporation
Sector Other Medical Equipment, Supplies & Distribution